TP53 and ductal breast carcinoma in situ: On the other hand, DCIS that will progress to invasion demonstrates a broader variety of biological processes and pathways involved, such as hypoxia response, insulin/IGF, endothelin, hedgehog, p53, and PI3 kinase signaling pathways.